399 related articles for article (PubMed ID: 23220096)
1. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension.
Guo JJ; Yue PF; Lv JL; Han J; Fu SS; Jin SX; Jin SY; Yuan HL
Int J Pharm; 2013 Jan; 441(1-2):227-33. PubMed ID: 23220096
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of an orodispersible film containing drug nanoparticles.
Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
[TBL] [Abstract][Full Text] [Related]
3. Improved stability and oral bioavailability of Ganneng dropping pills following transforming lignans of herpetospermum caudigerum into nanosuspensions.
Li JJ; Cheng L; Shen G; Qiu L; Shen CY; Zheng J; Xu R; Yuan HL
Chin J Nat Med; 2018 Jan; 16(1):70-80. PubMed ID: 29425592
[TBL] [Abstract][Full Text] [Related]
4. Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension.
Wang Y; Liu Z; Zhang D; Gao X; Zhang X; Duan C; Jia L; Feng F; Huang Y; Shen Y; Zhang Q
Colloids Surf B Biointerfaces; 2011 Apr; 83(2):189-97. PubMed ID: 21176876
[TBL] [Abstract][Full Text] [Related]
5. Formulation and optimization of a novel oral fast dissolving film containing drug nanoparticles by Box-Behnken design-response surface methodology.
Shen C; Shen B; Xu H; Bai J; Dai L; Lv Q; Han J; Yuan H
Drug Dev Ind Pharm; 2014 May; 40(5):649-56. PubMed ID: 24506458
[TBL] [Abstract][Full Text] [Related]
6. Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability.
Shen G; Cheng L; Wang LQ; Zhang LH; Shen BD; Liao WB; Li JJ; Zheng J; Xu R; Yuan HL
Chin J Nat Med; 2016 Oct; 14(10):757-768. PubMed ID: 28236405
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspension.
Li W; Yang Y; Tian Y; Xu X; Chen Y; Mu L; Zhang Y; Fang L
Int J Pharm; 2011 Apr; 408(1-2):157-62. PubMed ID: 21295124
[TBL] [Abstract][Full Text] [Related]
8. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
[TBL] [Abstract][Full Text] [Related]
9. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
Nagaraj K; Narendar D; Kishan V
Drug Dev Ind Pharm; 2017 Jul; 43(7):1186-1196. PubMed ID: 28271908
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of herpetolide A nanosuspension lyophilized powder and evaluation of its anti-hepatitis B virus activity].
Zhong YJ; Liu QC; Zhang T; Liu X; Wang LQ; Yuan HL
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(5):1076-1081. PubMed ID: 32237449
[TBL] [Abstract][Full Text] [Related]
11. Enhanced intestinal absorption activity and hepatoprotective effect of herpetrione via preparation of nanosuspensions using pH-dependent dissolving-precipitating/homogenization process.
Shen B; Jin S; Lv Q; Jin S; Yu C; Yue P; Han J; Yuan H
J Pharm Pharmacol; 2013 Sep; 65(9):1382-92. PubMed ID: 23927477
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
Du B; Li XT; Zhao Y; A YM; Zhang ZZ
Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
Ige PP; Baria RK; Gattani SG
Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
[TBL] [Abstract][Full Text] [Related]
14. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
15. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S
Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182
[TBL] [Abstract][Full Text] [Related]
16. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
Freag MS; Elnaggar YS; Abdallah OY
Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
[TBL] [Abstract][Full Text] [Related]
17. Nanosuspension for parenteral delivery of a p-terphenyl derivative: preparation, characteristics and pharmacokinetic studies.
Tian X; Li H; Zhang D; Liu G; Jia L; Zheng D; Shen J; Shen Y; Zhang Q
Colloids Surf B Biointerfaces; 2013 Aug; 108():29-33. PubMed ID: 23528604
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of isradipine nanosuspension by anti-solvent microprecipitation-high-pressure homogenization method for enhancing dissolution rate and oral bioavailability.
Shelar DB; Pawar SK; Vavia PR
Drug Deliv Transl Res; 2013 Oct; 3(5):384-91. PubMed ID: 25788346
[TBL] [Abstract][Full Text] [Related]
19. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
[TBL] [Abstract][Full Text] [Related]
20. Application of spray granulation for conversion of a nanosuspension into a dry powder form.
Bose S; Schenck D; Ghosh I; Hollywood A; Maulit E; Ruegger C
Eur J Pharm Sci; 2012 Aug; 47(1):35-43. PubMed ID: 22565066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
